2024 ISPE Pharma 4.0™ and Annex 1 Conference Featured Speakers Are Announced
Summary
This conference fuses digital transformation and Annex 1, providing pharmaceutical professionals and regulators with the opportunity to delve into the latest developments in these key areas. Attendees will receive first-hand insights from experts working on industry guidelines, regulators from around the world, and leading companies with case studies as well as real-world examples of how experts are dealing with various challenges impacting the industry daily, including regulatory guidance (e.g., pertaining to Annex 1), digital transformation (e.g., AI/ML, robotics, digital twins), the rapidly evolving ATMPs market, and interconnected facility design and construction. The insights gained are intended to have a significant positive impact on businesses: they can be tailored to optimize business strategies, roadmap upcoming plans with industry-level best practices, fine-tune goals by benchmarking progress with other industry leaders, and understand where competitors are focusing efforts or struggling. We place a high value on the exchange of ideas and collaborative learning at ISPE conferences, recognizing that these interactions are crucial for advancing our collective knowledge and fostering professional development. "We have chosen 24 abstracts to feature at this years conference and have structured them into attractive tracks that should provide ample inspiration and discussion opportunities."